Organogenesis Holdings Inc. (ORGO) Social Stream



Organogenesis Holdings Inc. (ORGO): $2.72

-0.02 (-0.73%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ORGO to Watchlist
Sign Up

Industry: Biotech


Ranked

of 381

in industry

ORGANOGENESIS HOLDINGS INC (ORGO) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ORGO.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-22 2 $29 $26.001 $27.5 $2.83 871.73%
2021-11-10 2 $26 $20 $23 $2.83 712.72%
2022-01-24 1 $26 $13 $19.5 $2.83 589.05%
2022-05-10 2 $21 $13 $17 $2.83 500.71%
2022-05-11 1 $14 $14 $14 $2.83 394.7%
NA 2 $NA $NA $NA $2.83 NA%

The Trend in the Analyst Price Target


ORGO's average price target has moved up $4 over the prior 16 months.

Over the past 107 days, ORGO's average upside potential has been 142.16%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-01-24 1 26 13 19.5 7.53 158.96%
2022-03-02 2 21 13 17.0 8.79 93.4%
2022-05-10 2 21 13 17.0 5.53 207.41%
2022-05-11 2 14 14 14.0 5.88 138.1%
2022-05-11 2 14 13 13.5 5.88 129.59%

ORGO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


ORGO's average broker recommendation rating improved by 0 over the prior 120 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ORGO as an investment opportunity.

  • ORGO has a higher number of analysts covering the stock than 18.35% of all US stocks.
  • In terms of how ORGANOGENESIS HOLDINGS INC fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 664.15% of that group.
  • ORGANOGENESIS HOLDINGS INC's variance in analysts' estimates is lower than -27.03% of Pharmaceutical Products stocks.
  • ORGANOGENESIS HOLDINGS INC's average analyst price target is greater than 173.03% of stocks in the mid market cap category.

In the Pharmaceutical Products industry, BPMC, QURE, and XNCR are the three stocks most similar to ORGANOGENESIS HOLDINGS INC regarding the price target and analyst recommendation information presented here.

Is ORGO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6464 seconds.